Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative...
Research Team of Shandong University Reveals Global Overconsumption Driving Earth Breach Safe Boundaries
JINAN, China, Nov. 21, 2024 /PRNewswire/ -- Recently, the Weihai Institute for Interdisciplinary Research team of Shandong University, in collaboration with multiple research teams both domestically and internationally, has made advancements in...